Interestingly, THOR hypermethylation is more common in cancers known to have a low frequency of hTERTp (prostate, lung, colon, and breast cancer), indicating THOR hypermethylation as an alternative hTERT activation mechanism for these tumor types. This evidence concerns the gene THORLNC and cancer.